Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Over the past, a new field of materials science has emerged as biomaterial. A biomaterial is any substance to fix the defects, repair or replacement of defective organ in the body. Dental biomaterial biomaterials gradually emerged over the last thirty years, especially in developed countries such as United States of America, and now has allocated a huge number of world trade and over 500 companies operating in it. Dental biomaterials are mainly used to replace damaged or lost tooth substance, teeth and jawbone. They are used for filings, crowns, bridges, implants and removable prosthetics.
The growth of this market is driven by various factors such as,
Demographics: more elderly people need tooth replacement as the population ages
Affordability: the middle class is growing in developing countries
Adoption: the number of trained dentists who are confident placing implants is rising
Awareness: patients are better informed about the negative effects of poor oral health
The geriatric population and corresponding age-related dental diseases, increasing prevalence of dental disorders is the key factor boosting the growth of the market. For instance, the number of Americans ages 65 and older is projected to more than double from 46 million today to over 98 million by 2060. With the increasing ageing population, the market of dental biomaterials is likely to grow.
The widespread disruption caused by the coronavirus has impacted many industries including dental market. Many companies are facing the heat of lockdown due to COVID 19 pandemic. The dental world’s biggest companies like Straumann have announced the drop in sales For instance, the Straumann Group CEO, Guillaume Daniellot, announced that the outbreak was likely to dent its sales in the Asia Pacific (APAC) region in the first quarter of 2020 by at least CHF 30 million (€28.36 million).
Dental Biomaterials Market Segmental Highlights
The report analyses the global dental biomaterials market based on type, application, end user and geography.
On the basis of type, the market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials. Even though, metal-free dental sciences have been developed more rapidly, the demand of the metals biomaterial is likely to remain the same owing to its durable and long-lasting clinical applications.
The market finds application in implantology, prosthodontics, orthodontics etc. Implantology is the branch of dentistry dedicated to dental implants. Whereas orthodontics deals with the correction of the improper jaws and teeth to improve the appearance and function of the teeth and jaws.
The major end users of the market are dental implant and prosthetic manufacturers, dental laboratories, dental hospitals & clinics and dental academies & research institutes
The dental biomaterials market is studied for the key regions including North America, Europe, Asia Pacific and Rest of the World. Asia Pacific is anticipated to be the fastest-growing region over the forecast period attributed to the growing economy in countries such as China and India coupled with the increasing disposable income. Moreover, the increasing ageing populace in Asian countries such as Japan offers untapped opportunities for the growth of the market.
Key players in the global dental biomaterials market includes Key players in the global Dental Biomaterials market includes Straumann AG,Henry Schein, Inc. , Mitsui Chemicals ,Inc. , Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation , Keystone Dental, Inc., Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation , Dentsply Sirona, Inc., 3M Company, Royal DSM (Netherlands), , Geistlich Pharma AG , Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Carpenter Technology Corporation, Kuraray Co., Ltd, Medtronic Plc., Carpenter Technology Corporation, Kuraray Co., Ltd , Medtronic Plc., Datum Dental Ltd, BEGO Medical GmbH , and Cam Bioceramics B.V among other.
Key Developments
June 2018: The Israeli Company Datum Dental has received approval to launch a biomaterial for dental implants in Europe and Canada.
October 2018: Straumann announced the launch of several new products, including a new two-piece ceramic implant and a mini-implant system.
The report analyses the global dental biomaterials market based type, application end user and geography. On the basis of type, the market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials. The market finds application in Implantology, Prosthodontics, Orthodontics etc. The major end users of the market dental biomaterial includes manufacturers, dental laboratories, dental hospitals & clinics and dental academies & research institutes. The dental biomaterials market is studied for the key regions including North America, Europe, Asia Pacific and Rest of the World.
Key players in the global Dental Biomaterials market includes Straumann AG,Henry Schein, Inc. , Mitsui Chemicals ,Inc. , Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation , Keystone Dental, Inc., Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation , Dentsply Sirona, Inc., 3M Company, Royal DSM (Netherlands), , Geistlich Pharma AG , Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Carpenter Technology Corporation, Kuraray Co., Ltd, Medtronic Plc., Carpenter Technology Corporation, Kuraray Co., Ltd , Medtronic Plc., Datum Dental Ltd, BEGO Medical GmbH , and Cam Bioceramics B.V among other.
Why to buy this report:
